Here are the three most asked questions I’ve been getting about the coronavirus pandemic. To answer them, I will digress in this post from this blog's core mission of advocacy for U.S. healthcare reform. What Are Worst-Case and Best-Case Scenarios? The worst case scenario was the 1918 Spanish flu pandemic. This graphic depicts its three … Continue reading Coronavirus FAQs: Will we get through this?
I came across this YouTube video from November 2017. It boils Fixing U.S. Healthcare blog's message down to a 5-minute kernel. I hope you find it entertaining, engaging, and informative. Permission: Copyright 2017. Permission to Share is granted by Vox Media.
I say Bravo for this cogent piece by Henry Kotula laying out the key conceptual driver of exorbitant healthcare prices – inadequate assessment of value for dollars spent. I argue in this Fixing U.S. Healthcare blog that only a national single-payer system would have sufficient reach and clout to assess cost-benefit and then act – over against blowback from vested interests.
Here are some additional factoids:
1. The Oregon Health Plan of 1994 did use cost-benefit analysis to prioritize services. See my previous post: The Big Fix
2. The Affordable Care Act Section 6301 provides for “comparative clinical effectiveness research,” but then prohibits the Secretary from using evidence and findings from research to make a determination regarding Medicare coverage unless “through an iterative and transparent process which includes public comment and considers the effect on subpopulations” (which seems reasonable, and mirrors what was done in Oregon). Link: https://www.gao.gov/hcac/pcor_sec_6301.pdf
3. FDA’s current approach to technology assessment is potentially flawed and susceptible to gaming. See my posts: Even Research Statistics Are Rigged and It’s Not Just About Costly Drugs, It’s Testing Too
4. The U.K.’s National Institute for Health Research does technology assessment and uses results to provide “guidance” on coverage priorities. Link: https://www.nihr.ac.uk/explore-nihr/funding-programmes/health-technology-assessment.htm
Discussions such as this by Henry Kotula add texture to the current debate over healthcare reform. I hope Henry Kotula will keep them coming! Enjoy this re-post!
If it followed the path of traditional Medicare, it would end up paying for a lot of coverage that has little medical value.
In the first congressional hearing held on “Medicare for all” in April, Michael Burgess, a Republican congressman from Texas and a physician, called such a proposal “frightening” because it could limit the treatments available to patients.
The debate over Medicare for all has largely focused on access and taxpayer cost, but this raises a question that hasn’t gotten much attention: What treatments would it cover?
A good starting place for answers is to look at how traditional Medicare currently handles things. In one sense, there are some important elements that Medicare does not cover — and arguably should. But a little digging into the rules governing treatments also reveals that Medicare allows a lot of low-value care — which…
View original post 977 more words
Henry Kotula’s first-person report on going back and forth between U.S.’s chaotic system and Britain’s single-payer is not only a compelling read, but also a credible glimpse into on-the-ground impact for an average patient of Medicare-for-all. Enjoy this re-post!
Earlier this year, I shattered my elbow in a freak fall, requiring surgery, plates and screws. While I am a US citizen, several years ago I married an Englishman and became a UK resident, entitled to coverage on the British National Health Service. My NHS surgeon was able to schedule me in for the three-hour surgery less than two weeks after my fall, and my physical therapist saw me weekly after the bone was healed to work on my flexion and extension. Both surgery and rehab were free at the point of use, and the only paperwork I completed was my pre-operative release forms.
View original post 1,178 more words
Why is it so bad for health spending to increase? After all, health care is good and noble. By the way, it also creates good-paying jobs. My answer, excerpted from Segment 6 of my Video Series, is that healthcare spending is good, of course, but only up to a point. Past a certain point it … Continue reading The Problem of Diminishing Marginal Benefit in Healthcare